CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $854K invested in Can-Fite BioPharma in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$722K
2
+$6.29K

Top Sellers

1
-$265K
2
-$190K
3
-$61.7K
4
Goldman Sachs
Goldman Sachs
New York
-$23K
5
Citadel Advisors
Citadel Advisors
Florida
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$763K
2
$48K
3
$27K
4
$11K
5
$4K
6
$1K
7
–
8
–
9
–
10
–
11
–
12
–